David
David is 62 and before giving up his job, worked as a self-employed handyman and bicycle mechanic. He is married with two adult children, who are 27 and 29. Ethnicity: White British.
David lost his mother to MND as a teenager. After developing symptoms in 2019, he was diagnosed with MND caused by the C9orf72 genetic variant. David tries to keep up with research and hopes that having information will help members of his family make informed choices.
David first experienced MND in his teenage years, when his mother developed the disease. He helped care for her during her illness, which was a difficult period in his life. In 2019, David noticed weakness in his right hand and foot. Whilst he questioned from the very beginnin whether he could have MND, as he recognised the early symptoms from his mother, he spent the months that followed undergoing investigations into other causes, including peripheral neuropathy and a vitamin B12 deficiency. Although he had been told in the past that MND was not inheritable, he did some research and discovered that this was not the case.
Eventually, David was referred to a neurologist and was diagnosed with MND around a year after he developed symptoms. Knowing his family history, he also sent off for genetic tests, which identified his condition was caused by the C9orf72 genetic variant. He now believes that his maternal grandmother, aunt, and her son, who all died of early-onset dementia, could have also carried the gene variant.
David has used an ancestry website to study his family history and trace the disease through previous generations. He believes that knowing who could have been affected and who may be at an increased genetic risk will give other family members the knowledge to make decisions around genetic testing, including before or during pregnancy, which could prevent MND in future generations. He has spoken to his sister and her husband about talking to their own children, and plans to contact his extended relatives about the family history. Having such discussions is a delicate thin, and David wants to make sure that he does so in the most supportive way he can.
David has had conversations with his children about pre-symptomatic genetic testing and options around starting a family. He acknowledges that they are in a very different situation than he was, because they will spend much of their adult lives knowing about the possibility that they could develop the disease. He therefore supports their decision to have genetic testing, and feels that the 50% chance they could then live their lives knowing that they don’t carry the gene variant is good odd. If they receive a positive result, he is confident that gene therapies will be available by the time they may develop symptoms.
Although he emphasises that every person with MND is different, David has both personal and professional experience of caregiving and knows what is involved in this role. He feels that his family have yet to fully grasp what is coming. Whilst he is still able, he has started to make changes to his home so that areas such as his garden will still be accessible to him as he becomes less mobile.
David is hopeful for a treatment or cure for MND, if not for himself for future generations. Even prior to his diagnosis, he started looking into information on MND and the research around this. He uses various sources including talking to people he knows who work in relevant fields and reading scientific papers to keep up to date with progress in this area. Based on what he has found, he has sourced two medications already used to treat other conditions, which have been hailed as promising treatments for MND based on either pre-clinical or early stage clinical trials. He now takes these alongside riluzole and believes that he has maintained strength and even built muscle in areas unaffected by MND. He is seeking opportunities to participate in clinical research, and has joined an online research programme after attending a virtual symposium, which he found inspiring;. David encourages people affected by MND to challenge the disease where they can, and to keep goin.